PHARMAZEUTISCHE ZUSAMMENSETZUNG
European patent · EP3908321 · In force
Register entry
- Publication number
- EP3908321
- Application number
- EP20700453
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 8, 2020
- Published
- Nov 17, 2021
- Granted
- Nov 15, 2023
- Protection ends at the latest
- Jan 7, 2040
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 47/34 (2017.01)A61K 9/00 (2006.01)A61K 31/445 (2006.01)
- Priority
- GB 201900258 08.01.2019
- PCT application
- PCT/EP2020/050333 08.01.2020
- PCT publication
- WO2020/144239 16.07.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
- Sep 25, 2024
Change
Published in Swissreg on 25.09.2024
- Feb 1, 2024
Change
Published in Swissreg on 01.02.2024
- Nov 15, 2023
Granted
Published in Swissreg on 15.11.2023
Parties
Inventor
OSTER, Murielle
34830 Jacou, FR
LIU, Fang
34830 Jacou, FR
LOPEZ NORIEGA, Adolfo
34830 Jacou, FR
GUÉGAIN, Elise
34830 Jacou, FR
GRIZOT, Sylvestre
34830 Jacou, FR
ROBERGE, Christophe
34830 Jacou, FR
VRLINIC, Tjasa
34830 Jacou, FR
CROS, Jean Manuel
34830 Jacou, FR
NG, Feifei
34830 Jacou, FR
CAGNON, Marie-Emérentienne
34830 Jacou, FR
MOLINIER, Charlotte
34830 Jacou, FR
SERINDOUX, Juliette
34830 Jacou, FR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.